

Author: Ström O. Leonard C. Marsh D. Cooper C.
Publisher: Springer Publishing Company
ISSN: 0937-941X
Source: Osteoporosis International, Vol.21, Iss.9, 2010-09, pp. : 1599-1608
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content


By Shindle M. Gardner M. Koob J. Bukata S. Cabin J. Lane J.
Osteoporosis International, Vol. 17, Iss. 12, 2006-12 ,pp. :








The Cost-Effectiveness of Losartan versus Captopril in Patients with Symptomatic Heart Failure
Cardiology, Vol. 91, Iss. 3, 1999-09 ,pp. :